USFDA Made 9 Observations Post Halol Unit Inspection: Sun Pharma
Sun Pharma was earlier issued a warning letter by the USFDA for its Halol facility in December 2015.08-12-2016
08-12-2016
FDA made 9 observations post Halol unit inspection: Sun Pharma
Sun Pharmaceutical Industries today said that the US health regulator has made nine observations after the completion of inspection of its Halol facility in Gujarat. The United States Food and...08-12-2016
Update on USFDA Inspection for Halol facility
Sun Pharmaceutical Industries Ltd has informed BSE regarding "Update on USFDA Inspection for Halol facility".08-12-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayant S Sanghvi08-12-2016
Clarifies on news item
With reference to ET NOW dated December 07, 2016, quoting "USFDA informs that Halol issued 14 page Form 483 post inspection", Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of Clarification is enclosed.07-12-2016
Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on December 07, 2016, with reference to ET NOW dated December 07, 2016, quoting "USFDA informs that Halol issued 14 page Form 483 post inspection"The reply is awaited.07-12-2016
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments02-12-2016
Things looking better for Sun Pharma: ICICIdirect
Maybe fourth quarter onwards, things would stabilise but definitely in third quarter, there is a very high chance of a very huge impact on the earnings of staples companies.02-12-2016
Did Sun Pharma arm pay clinical trial workers in recalled notes?
In a major embarrassment to India Inc, the country's largest drug-maker Sun Pharmaceuticals' research arm, Sun Pharma Advanced Research, allegedly paid its clinical research workers in demonetised...30-11-2016
Sun Pharma, Cadila Healthcare recall products from US market
They are recalling one product each from the market on account of failure to meet the desired specification norms30-11-2016